Frequency of CYP2C9 (*2, *3 and IVS8-109A>T) allelic variants, and their clinical implications, among mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin

Literals

• bibo:doi
  • 10.3892/br.2019.1204
• fabio:hasPublicationYear
  • 2019
• dcterms:creator
  • Cuautle-Rodríguez P.
• dcterms:contributor
  • Cuautle-Rodriguez P., Rodriguez-Rivera N., DE ANDRES F., Castillo-Najera F., Llerena A., Molina-Guarneros J.A.
• ou:eid
  • 2-s2.0-85070394159
• bibo:eissn
  • 2049-9442
• vivo:identifier
  • 2019-1188
• bibo:issn
  • 2049-9434
• bibo:page_range
  • 283-295
• dcterms:publisher
  • Biomedical Reports
• ou:tipoPublicacion
  • Article
• dcterms:title
  • Frequency of CYP2C9 (*2, *3 and IVS8-109A>T) allelic variants, and their clinical implications, among mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin
• vcard:url
  • https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85070394159&origin=inward
• ou:urlScopus
  • https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85070394159&origin=inward
• bibo:volume
  • 10

Typed Literals

• ou:openaccess
  • True (xsd:boolean)
• ou:vecesCitado
  • 5 (xsd:integer)

Relations

• ou:publicadaEnRevista
  • Biomedical Reports

Inverse Relations

• Has related: ou:tienePublicacion
  • ADRIÁN LLERENA RUIZ